Loriot Y, Petrylak DP, Rezazadeh Kalebasty A, Flechon A, et al. TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes. Ann Oncol 2024;35:392-401.
PMID: 38244927